RaDVaC Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

SMILES:

CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=…

InChI Key:

KTUFNOKKBVMGRW-UHFFFAOYSA-N

ClinicalTrials.gov PubMed

Clinical Development by Virus5

Severe acute respiratory syndrome-related coronavirus

SARS-CoV-2

Target: Human PTK

Phase 3

Preclinical

Phase 2negative

Phase 3

Approved

Phase 2 ref (PMID:36639911) Phase 3 ref (ccforum.biomedcentral.com) NCT04394416

Human polyomavirus 1

BKV

Target: Human PTK

Preclinical

Preclinical

Phase 2

Phase 3

Approved

HCV

Target: Human PTK

Preclinical

Preclinical

Phase 2

Phase 3

Approved

Middle East respiratory syndrome-related coronavirus

MERS-CoV

Target: Human PTK

Preclinical

Preclinical

Phase 2

Phase 3

Approved

Severe acute respiratory syndrome-related coronavirus

SARS-CoV

Target: Human PTK

Preclinical

Preclinical

Phase 2

Phase 3

Approved